enrasentan has been researched along with 1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)- in 5 studies
| Studies (enrasentan) | Trials (enrasentan) | Recent Studies (post-2010) (enrasentan) | Studies (1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)-) | Trials (1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)-) | Recent Studies (post-2010) (1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)-) |
|---|---|---|---|---|---|
| 32 | 2 | 0 | 123 | 3 | 1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dixon, DB; Jae, HS; Marsh, KC; Nguyen, B; Opgenorth, TJ; von Geldern, TW; Winn, M | 1 |
| Elliott, JD; Guiney, S; Luengo, JI; Ohlstein, EH; Sauermelch, CF; Storer, BL; Willette, RN; Xiang, JN | 1 |
| Ellens, HM; Elliott, JD; Lago, MA; Ohlstein, EH; Peishoff, CE | 1 |
| Dennis, MJ; Louden, C; Treinen, KA; Wier, PJ | 1 |
| Aiyar, N; Bingham, S; Elliott, JD; Hunter, AJ; Ohlstein, EH; Parsons, AA; Raval, P | 1 |
1 review(s) available for enrasentan and 1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)-
| Article | Year |
|---|---|
Endothelin receptor antagonists.
Topics: Amino Acid Sequence; Animals; Carboxylic Acids; Drug Design; Endothelin Receptor Antagonists; Humans; Indans; Molecular Sequence Data; Structure-Activity Relationship | 1998 |
4 other study(ies) available for enrasentan and 1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)-
| Article | Year |
|---|---|
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 2. Sulfonamide-based ETA/ETB mixed antagonists.
Topics: Administration, Oral; Animals; Atrasentan; Endothelin Receptor Antagonists; Half-Life; Male; Models, Chemical; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Structure-Activity Relationship | 1997 |
Plasma- and cerebrospinal fluid-immunoreactive endothelin-1: effects of nonpeptide endothelin receptor antagonists with diverse affinity profiles for endothelin-A and endothelin-B receptors.
Topics: Animals; Benzofurans; Carboxylic Acids; Dogs; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Indans; Injections, Intravenous; Injections, Intraventricular; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Propionates; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Vasoconstrictor Agents; Viper Venoms | 1998 |
Developmental toxicity and toxicokinetics of two endothelin receptor antagonists in rats and rabbits.
Topics: Abnormalities, Drug-Induced; Animals; Area Under Curve; Carboxylic Acids; Dose-Response Relationship, Drug; Embryonic and Fetal Development; Endothelin Receptor Antagonists; Female; Fetus; Indans; Male; Pregnancy; Rabbits; Rats; Rats, Sprague-Dawley; Teratogens | 1999 |
Trigeminal nerve ganglion stimulation-induced neurovascular reflexes in the anaesthetized cat: role of endothelin(B) receptors in carotid vasodilatation.
Topics: Anesthesia; Animals; Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Calcitonin Gene-Related Peptide; Carboxylic Acids; Carotid Arteries; Cats; Dioxoles; Electric Stimulation; Endothelin Receptor Antagonists; Guanethidine; Heart Rate; Hemodynamics; Indans; Male; Oligopeptides; Peptide Fragments; Piperidines; Pyrazoles; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Reflex; Sympatholytics; Time Factors; Trigeminal Ganglion; Trigeminal Nerve; Vascular Resistance; Vasodilation | 1999 |